Table 3 of Cevik, Mol Vis 2023; 29:217-233.


Table 3. Structure analysis and overall pathogenicity assessments of the missense ABCA4 variants found in the study.

Domain ABCA4 variants Clinical significance Functional in vitro studies Pathogenicity RMSD In silico Protein structural changes
prediction ∆∆G exp. (kcal/mol)
ECD1 c.161G>A:p(C54Y) P/LP - P 1.263 41.7 Broken disulfide bond, clashes
  c .634C>T:p(R212C) P/LP ↓ Expression20, 62, ↓ΑΤP binding20, Basal&Stim. ΑΤPase62 P 0.971 1.26 Broken H bond
  c .1622T>C:p(L541P) CI Mislocalization, ¯ Basal&Stim. ATPase17,20 P 1.271 7.65 Buried Pro introduced, broken helix
NBD1 c.3113C>T:p(A1038V) P/LP ↓ Basal&Stim. ΑΤPase17, Normal subcellular localization23 B 1.248 6.6 Slight conformation change
  c .3292C>T:p(R1098C) P/LP - P 1.217 2.49 Lost salt bridge with Asp-2242
RD1 c.3758C>T:p(T1253M) CI - P 1.392 1.54 Premature B-sheet, loss of H-bond
TMD2 c.4139C>T:p(P1380L) P/LP ↓ Basal&Stim. ATPase 19 P 1.264 12.2 Clashes, loss of the Pro-induced kink
ECD2 c.4793C>A:p(A1598D) P/LP ↓ Expression, ↓ Basal&Stim. ATPase 62 1.197 13.56 Clashes, buried hydrophilic introduced
NBD2 c.5882G>A:p(G1961E) CI ↓ Basal&Stim. ATPase 17,20 P 0.985 31.68 Clashes, buried hydrophilic introduced
RD2 c.6698A>T:p(E2233V) Novel - P 1.35 0.71 Loss of H-bond: RD2-NBD1 interaction *